Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Marianne Ifversen"'
Autor:
Lisa V.E. Oostenbrink, Erik G.J. von Asmuth, Cornelia M. Jol-van der Zijde, Anja M. Jansen-Hoogendijk, Carly Vervat, Robbert G.M. Bredius, Maarten J.D. van Tol, Marco W. Schilham, Petr Sedlacek, Marianne Ifversen, Adriana Balduzzi, Peter Bader, Christina Peters, Dirk Jan A.R. Moes, Arjan C. Lankester
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Anti T-lymphocyte globulin (ATLG) is used in hematopoietic stem cell transplantation (HSCT) to prevent graft-versus-host disease (GvHD) and graft failure. To date, insight in ATLG pharmacokinetics and -dynamics (PK/PD) is limited, and population PK (
Externí odkaz:
https://doaj.org/article/ce22bef36d7f40fda15533039f663591
Autor:
Kasper Mølgaard, Katrine Kielsen, Marianne Ifversen, Özcan Met, Inge Marie Svane, Klaus Müller
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
BackgroundRecovery and functional differentiation of T-cell subsets are central for the development of immune function and complications after allogeneic hematopoietic stem cell transplantation (HSCT), but little is known about the cellular respirati
Externí odkaz:
https://doaj.org/article/94cf024d68f94a25abc84cda9247619c
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100093- (2023)
Externí odkaz:
https://doaj.org/article/e639a10a688341599101e7ec7f7e0fa7
Autor:
Sidsel Mathiesen, Kaspar Sørensen, Marianne Ifversen, Casper P Hagen, Jørgen Holm Petersen, Anders Juul, Klaus Müller
Publikováno v:
Endocrine Connections, Vol 10, Iss 10, Pp 1352-1365 (2021)
Objectives: Longitudinal assessment of testicular function after pediatric hematopoietic stem cell transplantation (HSCT) is needed to guide clinical follow-up. We investigated dynamics in male reproductive hormones after pediatric HSCT, focusing on
Externí odkaz:
https://doaj.org/article/d908a48518f14af0b8d9a790e976a046
Autor:
Anna Cäcilia Ingham, Katrine Kielsen, Hanne Mordhorst, Marianne Ifversen, Frank M. Aarestrup, Klaus Gottlob Müller, Sünje Johanna Pamp
Publikováno v:
Microbiome, Vol 9, Iss 1, Pp 1-28 (2021)
Abstract Background Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) exhibit changes in their gut microbiota and are experiencing a range of complications, including acute graft-versus-host disease (aGvHD). It is unknown
Externí odkaz:
https://doaj.org/article/6765786a3e214527996dca87c814480f
Autor:
Adriana Balduzzi, Jochen Buechner, Marianne Ifversen, Jean-Hugues Dalle, Anca M. Colita, Marc Bierings
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
The ALL SCTped 2012 FORUM (For Omitting Radiation Under Majority age) trial compared outcomes for children ≥4 years of age transplanted for acute lymphoblastic leukaemia (ALL) who were randomised to myeloablation with a total body irradiation (TBI)
Externí odkaz:
https://doaj.org/article/1c846ce87b6d45adb5bf449767e8118f
Autor:
Melissa Gabriel, Bianca A. W. Hoeben, Hilde Hylland Uhlving, Olga Zajac-Spychala, Anita Lawitschka, Dorine Bresters, Marianne Ifversen
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Despite advances in haematopoietic stem cell transplant (HSCT) techniques, the risk of serious side effects and complications still exists. Neurological complications, both acute and long term, are common following HSCT and contribute to significant
Externí odkaz:
https://doaj.org/article/afe638ee3daa4a3fbd3e1885e024caea
Autor:
Pietro Merli, Marianne Ifversen, Tony H. Truong, Hanne V. Marquart, Jochen Buechner, Matthias Wölfl, Peter Bader
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Minimal residual disease (MRD) assessment plays a central role in risk stratification and treatment guidance in paediatric patients with acute lymphoblastic leukaemia (ALL). As such, MRD prior to haematopoietic stem cell transplantation (HSCT) is a m
Externí odkaz:
https://doaj.org/article/e0a0937ef4b44e059d9150d003ca4ae9
Autor:
Marianne Ifversen, Roland Meisel, Petr Sedlacek, Krzysztof Kalwak, Luisa Sisinni, Daphna Hutt, Thomas Lehrnbecher, Adriana Balduzzi, Tamara Diesch, Andrea Jarisch, Tayfun Güngör, Jerry Stein, Isaac Yaniv, Halvard Bonig, Michaela Kuhlen, Marc Ansari, Tiago Nava, Jean-Hugues Dalle, Cristina Diaz-de-Heredia, Eugenia Trigoso, Ulrike Falkenberg, Mihaela Hartmann, Marco Deiana, Marta Canesi, Chiara Broggi, Alice Bertaina, Brenda Gibson, Gergely Krivan, Kim Vettenranta, Toni Matic, Jochen Buechner, Anita Lawitschka, Christina Peters, Akif Yesilipek, Koray Yalçin, Giovanna Lucchini, Shahrzad Bakhtiar, Dominik Turkiewicz, Riitta Niinimäki, Jacek Wachowiak, Simone Cesaro, Arnaud Dalissier, Selim Corbacioglu, Andre Manfred Willasch, Peter Bader
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Specific protocols define eligibility, conditioning, donor selection, graft composition and prophylaxis of graft vs. host disease for children and young adults undergoing hematopoietic stem cell transplant (HSCT). However, international protocols rar
Externí odkaz:
https://doaj.org/article/fe963302e404415bb2c35dccbfde5188
Autor:
Lisa V. E. Oostenbrink, Cornelia M. Jol-van der Zijde, Katrine Kielsen, Anja M. Jansen-Hoogendijk, Marianne Ifversen, Klaus G. Müller, Arjan C. Lankester, Astrid G. S. van Halteren, Robbert G. M. Bredius, Marco W. Schilham, Maarten J. D. van Tol
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Anti-thymocyte globulin (ATG) is a lymphocyte depleting agent applied in hematopoietic stem cell transplantation (HSCT) to prevent rejection and Graft-vs.-Host Disease (GvHD). In this study, we compared two rabbit ATG products, ATG-Genzyme (ATG-GENZ)
Externí odkaz:
https://doaj.org/article/8044e135e7df45b3a36d392be8be61d7